Francesc Bosch, MD, PhD

Head, Dept of Hematology; Director, Experimental Hematology (VHIO); Professor
Universtitat Autonoma Barcelona, Hospital Universitari Vall d'Hebron, Spain

Poster(s):

• 1019 - Immunological Landscape of CLL Development and Response to Early BTK Inhibition in del(13q14) Mice

• 1106 - Genomic characterization of chronic lymphocytic leukemia patients with TP53 alterations from a spanish real-world cohort treated with targeted agents

• 1118 - Optical genome mapping identifies a high number of chromoanagenesis events in chronic lymphocytic leukemia patients with altered TP53

• 1212 - High-dimensional profiling of CLL and T cell interactions during early phase of disease using a 42-color full-spectrum cytometry panel

• 1416 - CLL18 / MOIRAI: an international phase-III trial aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes in first-line treatment of CLL/SLL